Popular Articles

Feb 12, 2014
By Pharmaceutical Executive Editors
In the latest issue of PEGD: Face-to-Face Meetings in the Digital Age; the US Rx Rep in the Obamacare Era; the Future of the iPad — And more
Feb 01, 2014
Pharmaceutical Executive
Millennium Takeda's new president, Anna Protopapas, explains the life choices that brought her from Cyprus to Cambridge—and a lead position in the hotly contested search to make cancer a treatable disease.
Jan 21, 2014
Pharmaceutical Executive
For Big Pharma, the merits of strategic focus and operational discipline are more important than ever. It is time to be decisive — muddling through is so yesterday.
Dec 01, 2013
Pharmaceutical Executive
For Patrick Lindsay, providing decision support across the full product life cycle is no stretch goal—it's today's fact of life
Mar 27, 2012
By Pharmaceutical Executive Editors
The quest for 'radical' R&D innovation is often pursued at the expense of treatments with hidden blockbuster potential, writes Bert Spilker.
Mar 07, 2012
Jim Currie and Baber Ghauri talk to Pharm Exec about making connections that resonate with audiences in a digital world.
Mar 01, 2012
Pharmaceutical Executive
Our annual press audit finds that the big news in 2011 for pharma was ... no news.
Jan 01, 2012
Pharmaceutical Executive
Pharma has become unusually quick to strike embrace the iPad. But the industry's inherent conservatism means it has some way to go to fully milk the device's potential.
Jan 01, 2012
Pharmaceutical Executive
The challenge for 2012 is that many new treatments may not complete the move from 'bench to bedside' in time to plug the yawning revenue gap.
Jan 01, 2012
Pharmaceutical Executive
A selection of the recent breakthrough technologies showcased at the Cleveland Clinic's Medical Innovations Summit.
native1_300x100
lorem ipsum